HIV medicine for dermatologists and venereologists.
Journal
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
ISSN: 1610-0387
Titre abrégé: J Dtsch Dermatol Ges
Pays: Germany
ID NLM: 101164708
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
30
06
2020
accepted:
04
08
2020
pubmed:
31
12
2020
medline:
10
8
2021
entrez:
30
12
2020
Statut:
ppublish
Résumé
Broad administration of combined antiretroviral therapy (ART) has dramatically reduced the morbidity and mortality of the HIV-infection and substantially improved the life expectancy of people living with HIV (PLWH). PLWH, who are effectively treated with an ART, are considered to be unable to transmit HIV. The standard of care is usually an antiretroviral single tablet regimen. Since 2015 the Robert Koch Institute has reported a slight decrease in the rate of recently diagnosed HIV-infections in Germany, but the proportion of late presenters (initial diagnosis in advanced stages of infection) has remained consistently high at around 32 % since 2005. HIV-infections have not been diagnosed in 10,800 PLWH so far. In comparison to the general population PLWH suffer more frequently from skin diseases. Depending on the stage of immunodeficiency, untreated PLWH develop HIV indicator diseases of the skin and the mucocutaneous membranes. Knowledge of these diseases facilitates the selection of individuals who should be offered HIV testing. Early diagnosis of HIV-infections allows early introduction of the ART, prevents the spread of HIV and reduces the mortality rates and treatment costs associated with late diagnosis. HIV is a predominantly sexually transmitted infection. Through focused sexual anamnesis and the diagnosis of HIV indicator diseases and other sexually transmitted infections, dermatovenereologists in particular may be able to identify previously undiagnosed PLWH and persons with an increased risk of HIV infection, enabling initiation of ART in the former and pre-exposure prophylaxis counseling in the latter.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
82-96Informations de copyright
© 2020 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.
Références
an der Heiden M, Marcus U, Kollan C et al. Schätzung der Zahl der HIV-Neuinfektionen und der Gesamtzahl von Menschen mit HIV in Deutschland, Stand Ende 2019. Epid Bull 2020; 48: 3-16.
Esser S. 15. HIV und sexuell übertragbare Erkrankungen (STDs). In: Hoffmann C, Rockstroh JK (Hrsg.): HIV 2020/2021; Medizin Fokus Verlag, Hamburg, 2020: 404-27.
Robert Koch-Institut. Syphilis in Deutschland im Jahr 2009. Epidemiologisches Bulletin Nr. 2010; 49: 13. S487-91.
Molina JM, Charreau I, Spire B et al. ANRS IPERGAY Study Group. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV 2017; 4(9): e402-10.
Serpa JA, Huynh GN, Nickell JB, Miao H. HIV Pre-exposure prophylaxis and increased incidence of sexually transmitted infections in the United States. Clin Infect Dis 2020; 70(9): 1884-90.
Robert Koch-Institut. Anstieg von Syphilis-Infektionen bei Männern, die Sex mit Männern haben, setzt sich weiter fort. Epidemiologisches Bulletin Nr. 2018; 46: 15.
Robert Koch-Institut. Syphilis in Deutschland im Jahr 2018 - Anstieg der Vorjahre stagniert auf hohem Niveau. Epidemiologisches Bulletin Nr. 2019; 50: 12.
Leitlinien für Diagnostik und Therapie der HIV-Infektion. Available from: https://daignet.de/site-content/hiv-leitlinien/leitlinien-1/deutsch-oesterreichische-leitlinien-zur-postexpositionellen-prophylaxe-der-hiv-infektion [Last accessed June 30, 2020].
Deutsch-Österreichische Leitlinien zur HIV-Präexpositionsprophylaxe. Available from: https://daignet.de/site-content/hiv-leitlinien/leitlinien-1/deutsch-oesterreichische-leitlinien-zur-hiv-praeexpositionsprophylaxe [Last accessed June 30, 2020].
Antragsformular. Available from: https://www.kvb.de/fileadmin/kvb/dokumente/Praxis/Formulare/E-H/KVB-FORM-Genehmigungsantrag-HIV-Praeexpositionsprophylaxe.pdf [Last accessed June 30, 2020].
Rothengatter S, Sehr T, Gholam P et al. Skin diseases and sexually transmitted diseases in HIV-infected patients on HAART compared to a non-infected population - results of a retrospective study. J Dtsch Dermatol Ges 2009; 7: 527-32.
Tan J, Pina A, Borges-Costa J. Skin diseases in the era of highly active antiretroviral therapy: a retrospective study of 534 patients. J Int Assoc Provid AIDS Care 2018; 17: 2325957417752255.
Esser S. 15. HIV und sexuell übertragbare Erkrankungen (STDs). In: Hoffmann C, Rockstroh JK (Hrsg.): HIV 2020/2021; Medizin Fokus Verlag, Hamburg, 2020; 537-46.
Chatzikokkinou P, Sotiropoulos K, Katoulis A et al. Seborrheic dermatitis - an early and common skin manifestation in HIV patients. Acta Dermatovenerol Croat 2008; 16: 226-30.
Sullivan AK, Raben D, Reekie J et al. Feasibility and effectiveness of indicator condition guided testing for HIV: results from HIDES I (HIV Indicator Diseases across Europe Study). PLoS One 2013; 8(1): e52845.
Itin PH, Battegay M. Mucocutaneous infections in immunosuppression. Internist (Berl) 2009; 50(2): 150-9.
Friedman-Kien AE. Disseminated Kaposi's sarcoma syndrome in young homosexual men. J Am Acad Dermatol 1981; 5: 468-71.
Gottlieb MS, Schroff R, Schanker HM et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. N Engl J Med 1981; 305: 1425-31.
Calista D, Morri M, Stagno A, Boschini A. Changing morbidity of cutaneous diseases in patients with HIV after the introduction of highly active antiretroviral therapy including a protease inhibitor. Am J Clin Dermatol 2002; 3: 59-62.
Hartmann M. [Dermatological signs of HIV-infection]. MMW Fortschr Med 2019; 161 (Suppl 2): 20-5.
Rudikoff D. The relationship between HIV infection and atopic dermatitis. Curr Allergy Asthma Rep 2002; 2: 275-81.
Coates SJ, Leslie KS. What's new in HIV dermatology? F1000Res 2019; 8: F1000 Faculty Rev-980.
Mitsuyasu RT. Non-AIDS-defining malignancies in HIV. Top HIV Med 2008, 16: 117-21.
Patel P, Hanson DL, Sullivan PS et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008, 148: 728-36.
Silverberg MJ, Leyden W, Warton EM et al. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst 2013; 105(5): 350-60.
Omland SH, Ahlström MG, Gerstoft J et al. Risk of skin cancer in patients with HIV: A Danish nationwide cohort study. J Am Acad Dermatol 2018; 79(4): 689-95.
Palefsky JM, Holly EA, Efirdc JT et al. Anal intraepithelial neoplasia in the HAART era among HIV-positive MSM. AIDS 2005, 19: 1407-14.
Esser S, Kreuter A, Oette M et al. German-Austrian guidelines on anal dysplasia and anal cancer in HIV-positive individuals: prevention, diagnosis, and treatment. J Dtsch Dermatol Ges 2015; 13: 1302-19.
Pineda CE, Berry JM, Jay N et al. High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience. Dis Colon Rectum 2008, 51: 829-35; discussion 835-7.
Revollo B, Videla S, Llibre JM et al. Routine screening of anal cytology in HIV-infected subjects and the impact on invasive anal cancer. A prospective cohort study. Clin Infect Dis 2020; 71(2): 390-9.
Burgi A, Brodine S, Wegner S et al. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer 2005; 104: 1505-11.
Ameen M. Cutaneous markers of HIV infection and progression. Curr HIV Res 2010, 8: 450-5.
Imaz A, Pujol M, Barragan P et al. Community associated methicillin-resistant Staphylococcus aureus in HIV-infected patients. AIDS Rev 2010, 12: 153-63.
HIV-Leitlinien Stand 4/2019. Available from: www.daignet.de/site-content/hiv-ltherapie/leitlinien-1 [Last accessed June 30, 2020].
HIV Drug Interactions. Available from: https://www.hiv-druginteractions.org/ [Last accessed June 30, 2020].